Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

5.0K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.0K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

192
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
192
Burn Injuries01:22

Burn Injuries

3.7K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
3.7K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

917
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
917
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

202
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
202
Skin Cancer01:30

Skin Cancer

5.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Type I and II Interferon Signalling Characterizes the Transcriptional Landscape of Sweet Syndrome.

Experimental dermatology·2026
Same author

Observational Study Profiling the Immune Microenvironment of Pregnancy-associated Melanoma.

The American Journal of dermatopathology·2026
Same author

Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.

Dermatology and therapy·2026
Same author

Role of the IL-15 pathway in vitiligo: Mechanistic insights and therapeutic implications.

The Journal of investigative dermatology·2026
Same author

CD19 CAR T Therapy Is Feasible in Patients with Pemphigus Vulgaris Treated Without Lymphodepletion in the RESET-PV Trial.

Blood·2026
Same author

Trichophyton mentagrophytes Genotype VII: Sexually Transmitted Infection Beyond MSM.

The Australasian journal of dermatology·2026

Related Experiment Video

Updated: Dec 6, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.8K

Pyoderma gangrenosum.

Emanual Maverakis1, Angelo V Marzano2,3, Stephanie T Le4

  • 1Department of Dermatology, University of California, Davis, Sacramento, CA, USA. emaverakis@ucdavis.edu.

Nature Reviews. Disease Primers
|October 9, 2020
PubMed
Summary

Pyoderma gangrenosum (PG) is a rare, painful skin ulcer condition. Early diagnosis and treatment with immunosuppressants and wound care are crucial for managing this autoinflammatory disorder.

More Related Videos

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

926

Related Experiment Videos

Last Updated: Dec 6, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.8K
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

926

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by rapidly progressing, painful ulcers with undermined borders.
  • It typically affects individuals in their mid-40s and is associated with immune-mediated diseases like inflammatory bowel disease and rheumatoid arthritis.
  • The exact cause of PG is unknown, but it is considered an autoinflammatory disorder potentially involving T cells and the innate immune system.

Purpose of the Study:

  • To provide a comprehensive overview of Pyoderma gangrenosum (PG).
  • To discuss diagnostic challenges and the importance of validated criteria.
  • To outline current and future treatment strategies for PG.

Main Methods:

  • Literature review of epidemiological, etiological, diagnostic, and therapeutic aspects of PG.
  • Analysis of the role of immune cells, particularly T cells, in PG pathogenesis.
  • Evaluation of current treatment modalities, including immunosuppressants and biologics.

Main Results:

  • PG diagnosis requires clinical examination and laboratory tests of biopsied tissue; new criteria aim to simplify this process.
  • Treatment involves initial rapid immunosuppression (corticosteroids, cyclosporine) followed by agents with better safety profiles (biologics, anti-TNF agents).
  • Effective wound care is a critical component of PG management.

Conclusions:

  • PG is a complex autoinflammatory condition requiring a multi-faceted approach to management.
  • Further research into PG-specific outcome measures and quality-of-life studies is warranted.
  • Timely diagnosis and appropriate treatment are essential for improving patient outcomes in Pyoderma gangrenosum.